Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAC Chemotherapy with GM-CSF in Advanced Breast Cancer
NCT00001239Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 1989
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sargramostim, fluorouracil, folinic acid, doxorubicin and cyclophosphamide in breast cancer, sponsored by National Cancer Institute. Primary endpoint: Objective Response Rate. Started Jul 1989; status: completed.
02
Drugs
sargramostimfluorouracilfolinic aciddoxorubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00001239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001239.